Absci (ABSI) Cash & Equivalents (2020 - 2026)
Absci (ABSI) posted Cash & Equivalents of $107.87 million for Q2 2026, up 183.7% from $38.02 million a year earlier.
Powered by 
Analysis
Absci (ABSI) Cash & Equivalents (2020 - 2026) Analysis & Trends
At the end of FY2025, Absci's Cash & Equivalents came in at $20.03 million, down 51.4% from FY2024.
- Annual Cash & Equivalents shows a five-year compound annual growth rate of -22.1% (FY2020 to FY2025).
- In prior years, Absci's Cash & Equivalents was $41.21 million in FY2024 (-43.0%), $72.36 million in FY2023 (+20.7%), $59.96 million in FY2022 (-76.3%) and $252.57 million in FY2021 (+261.5%).
- The Q2 2026 figure stands as the highest quarterly Cash & Equivalents since Q2 2022.
- On a year-over-year basis, Cash & Equivalents increased in 1 of the last eight quarters, with an average decline of 18.0%.
- The strongest year-over-year quarter for Cash & Equivalents in the past five years was Q1 2024, with growth of 415.7%; the weakest was Q1 2023, with a decline of 95.0%.
- According to Business Quant data, Cash & Equivalents for the three prior quarters was $8.63 million (Q1 2026), $20.03 million (Q4 2025) and $9.48 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 20.42 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 4.89 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 976.00 Mn |
| 10 | Absci | 1.90 Bn | 1.28 Bn | - | 107.87 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 107.87 Mn |
| Mar 31, 2026 | 8.63 Mn |
| Dec 31, 2025 | 20.03 Mn |
| Sep 30, 2025 | 9.48 Mn |
| Jun 30, 2025 | 38.02 Mn |
| Mar 31, 2025 | 47.00 Mn |
| Dec 31, 2024 | 41.21 Mn |
| Sep 30, 2024 | 38.20 Mn |
| Jun 30, 2024 | 42.94 Mn |
| Mar 31, 2024 | 58.83 Mn |
| Dec 31, 2023 | 72.36 Mn |
| Sep 30, 2023 | 69.73 Mn |
| Jun 30, 2023 | 61.05 Mn |
| Mar 31, 2023 | 11.41 Mn |
| Dec 31, 2022 | 59.96 Mn |
| Sep 30, 2022 | 107.32 Mn |
| Jun 30, 2022 | 206.02 Mn |
| Mar 31, 2022 | 226.00 Mn |
| Dec 31, 2021 | 252.57 Mn |
| Sep 30, 2021 | 279.26 Mn |
API Access
Absci Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=ABSI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "ABSI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=ABSI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();